Shiho Asaka Selected Research

olaparib

10/2020

Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiho Asaka Research Topics

Disease

15	Neoplasms (Cancer) 03/2024 - 12/2015
6	Adenocarcinoma 06/2023 - 01/2014
6	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2017
4	Hyperplasia 01/2023 - 09/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2018 - 01/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024 - 11/2017
2	Carcinogenesis 12/2023 - 02/2023
2	Carcinoma (Carcinomatosis) 12/2023 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 06/2023 - 02/2022
2	Cholangiocarcinoma 06/2023 - 04/2022
2	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 01/2019
2	Immunoglobulin G4-Related Disease 07/2021 - 12/2020
2	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 01/2019
2	Edema (Dropsy) 03/2017 - 01/2017
1	Squamous Cell Carcinoma of Head and Neck 03/2024
1	Pancreaticobiliary Maljunction 12/2023
1	Lymphatic Metastasis 06/2023
1	Margins of Excision 06/2023
1	Endometrioid Carcinoma 01/2023
1	Liver Neoplasms (Liver Cancer) 04/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Hyponatremia 01/2022
1	Inappropriate ADH Syndrome (SIADH) 01/2022
1	Castleman Disease (Castleman's Disease) 07/2021
1	Metaplasia 01/2021
1	Autoimmune Pancreatitis 12/2020
1	Papillomavirus Infections 10/2019
1	Genomic Instability 01/2019
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 09/2018
1	Pleural Effusion (Pleural Effusions) 06/2018
1	Fever (Fevers) 03/2017
1	Fibrosis (Cirrhosis) 03/2017
1	Renal Insufficiency (Renal Failure) 03/2017
1	Thrombocytopenia (Thrombopenia) 03/2017
1	Mycosis Fungoides 01/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017
1	Proteinuria 01/2017
1	Hematuria 01/2017

Drug/Important Bio-Agent (IBA)

3	Immunoglobulin G (IgG)IBA 03/2024 - 12/2020
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2019
3	ErbB Receptors (EGF Receptor)IBA 06/2018 - 02/2017
2	Interleukin-6 (Interleukin 6)IBA 06/2023 - 07/2021
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2023 - 02/2022
2	Leucine (L-Leucine)FDA Link 02/2023 - 02/2022
2	MucinsIBA 09/2018 - 12/2015
2	Tyrosine Kinase InhibitorsIBA 06/2018 - 02/2018
1	phytobacteriomycin (PBM)IBA 12/2023
1	SGI 1776IBA 05/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2023
1	Estrogen ReceptorsIBA 01/2023
1	Progesterone FDA LinkGeneric 01/2023
1	Messenger RNA (mRNA)IBA 04/2022
1	RNA (Ribonucleic Acid)IBA 04/2022
1	Cadherins (E-Cadherin)IBA 02/2022
1	ClaudinsIBA 02/2022
1	Vasopressins (Vasopressin)IBA 01/2022
1	Sucrase (Sucrose alpha-D-Glucohydrolase)IBA 01/2021
1	Oligo-1,6-Glucosidase (Isomaltase)IBA 01/2021
1	Combined Antibody TherapeuticsIBA 12/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2020
1	GlutaminaseIBA 10/2020
1	CB-839IBA 10/2020
1	EnzymesIBA 10/2020
1	Glutamine (L-Glutamine)FDA Link 10/2020
1	NucleotidesIBA 10/2020
1	Glutathione (Reduced Glutathione)IBA 10/2020
1	AntioxidantsIBA 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020
1	PlatinumIBA 10/2020
1	olaparibIBA 10/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Proline (L-Proline)FDA Link 09/2019
1	Odorant Receptors (Odorant Receptor)IBA 09/2019
1	Mucin-6IBA 01/2019
1	Retroelements (Retrotransposon)IBA 01/2019
1	Gastric MucinsIBA 01/2019
1	Staphylococcal Protein A (Protein A)IBA 01/2019
1	AcetylglucosamineIBA 01/2019
1	ElementsIBA 01/2019
1	Trefoil FactorsIBA 01/2019
1	Polysaccharides (Glycans)IBA 09/2018
1	Cell-Free Nucleic AcidsIBA 06/2018
1	Growth Factor ReceptorsIBA 02/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2017
1	Reticulin (Reticular Fiber)IBA 03/2017
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2017
1	Immunoglobulin A (IgA)IBA 01/2017
1	Serum AlbuminIBA 01/2017
1	Carcinoembryonic AntigenIBA 01/2017

Therapy/Procedure

6	Therapeutics 01/2023 - 02/2017
4	Drug Therapy (Chemotherapy) 10/2020 - 01/2017
2	Hysterectomy 10/2020 - 01/2019
1	Oral Administration 05/2023
1	Thoracotomy 01/2022
1	Conservative Treatment 10/2020
1	Radiotherapy 10/2019
1	Immunotherapy 01/2019